findmyKOL
Clinical trialNCT01794572TerminatedInterventional

Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse

SponsorInstitut Cancerologie de l'OuestEnrollment13Multiple Myeloma in Relapse
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Chu Haut-Leveque, Service D'Hématologie

    Bordeaux, France

  • Clcc Bergonie, Service de Radiotherapie

    Bordeaux, France

  • Chu Claude Huriez, Service D'Hématologie

    Lille, France

  • Clcc Oscar Lambret, Service de Radiothérapie

    Lille, France

  • Chu Hotel-Dieu, Service D'Hématologie

    Nantes, France

  • Clcc Ico, Service de Radiothérapie

    Saint-Herblain, France

  • Chu Hautepierre, Service D'Hématologie

    Strasbourg, France

  • Clcc Paul Strauss, Service de Radiothérapie

    Strasbourg, France

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
9 Apr 2013
Primary completion
6 Oct 2020
Completion
6 Oct 2020
Last update posted
12 Dec 2025
Registered enrollment
13
Registry id
NCT01794572

Cross-registrations

EU-CTR / CTIS (EudraCT)2012-001473-91

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.